JSPR
Jasper Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.47 / 10
Netural
Analyst sentiment is neutral, with one UBS analyst rating neutral and a low historical win rate (0%). Fund‑flow score is 7.55 (good), showing modest overall inflow (0.44) but mixed size trends—small and large positive, medium and extra‑large negative. Market outlook remains pessimistic.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-23
InstitutionUBS
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for JSPR?
- JSPR holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.47/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
